Literature DB >> 24100621

[Brugada syndrome].

Christian Wolpert1, Claudia Herrera-Siklody, Ulli Parade, Christian Strotmann, Norman Rüb.   

Abstract

Brugada syndrome is an ion channel disease which is associated with an increased risk of sudden cardiac death. Most probably the pathogenesis of ventricular fibrillation in these patients is a combination of both genetically determined repolarisation abnormalities and conduction delay in the right ventricular epicardium. The highest risk of sudden cardiac death is present in patients who have experienced syncope before, who reveal the pathognomic electrocardiographic changes already at rest and who have inducible ventricular fibrillation. Asymptomatic patients who have the J point elevations only after administration of a sodium channel blocker seem to be at lower risk. Most recently the latest joint consensus recommendations of the largest societies for diagnostic criteria, indications for genetic testing and therapy have been published.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100621     DOI: 10.1007/s00399-013-0294-2

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  54 in total

Review 1.  Proposed diagnostic criteria for the Brugada syndrome: consensus report.

Authors:  Arthur A M Wilde; Charles Antzelevitch; Martin Borggrefe; Josep Brugada; Ramón Brugada; Pedro Brugada; Domenico Corrado; Richard N W Hauer; Robert S Kass; Koonlawee Nademanee; Silvia G Priori; Jeffrey A Towbin
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

2.  Magnetic resonance imaging findings in patients with Brugada syndrome.

Authors:  Theano Papavassiliu; Christian Wolpert; Stephan Flüchter; Rainer Schimpf; Wolfgang Neff; Karl Konstantin Haase; Christoph Düber; Martin Borggrefe
Journal:  J Cardiovasc Electrophysiol       Date:  2004-10

3.  Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis.

Authors:  Anil K Gehi; Truong D Duong; Louise D Metz; J Anthony Gomes; Davendra Mehta
Journal:  J Cardiovasc Electrophysiol       Date:  2006-06

4.  Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation.

Authors:  Pieter G Postema; Pascal F H M van Dessel; Jan A Kors; Andre C Linnenbank; Gerard van Herpen; Henk J Ritsema van Eck; Nan van Geloven; Jacques M T de Bakker; Arthur A M Wilde; Hanno L Tan
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

5.  A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification.

Authors:  Christian Veltmann; Rainer Schimpf; Constanze Echternach; Lars Eckardt; Juergen Kuschyk; Florian Streitner; Susanne Spehl; Martin Borggrefe; Christian Wolpert
Journal:  Eur Heart J       Date:  2006-09-04       Impact factor: 29.983

6.  Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.

Authors:  Josep Brugada; Ramon Brugada; Pedro Brugada
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

7.  The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol.

Authors:  Sascha Rolf; Hans-Jürgen Bruns; Thomas Wichter; Paulus Kirchhof; Michael Ribbing; Kristina Wasmer; Matthias Paul; Günter Breithardt; Wilhelm Haverkamp; Lars Eckardt
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

8.  Natural history of Brugada syndrome: insights for risk stratification and management.

Authors:  Silvia G Priori; Carlo Napolitano; Maurizio Gasparini; Carlo Pappone; Paolo Della Bella; Umberto Giordano; Raffaella Bloise; Carla Giustetto; Roberto De Nardis; Massimiliano Grillo; Elena Ronchetti; Giovanna Faggiano; Janni Nastoli
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

9.  Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.

Authors:  Pietro Delise; Giuseppe Allocca; Elena Marras; Carla Giustetto; Fiorenzo Gaita; Luigi Sciarra; Leonardo Calo; Alessandro Proclemer; Marta Marziali; Luca Rebellato; Giuseppe Berton; Leonardo Coro; Nadir Sitta
Journal:  Eur Heart J       Date:  2010-10-26       Impact factor: 29.983

10.  Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death.

Authors:  Connie R Bezzina; Julien Barc; Yuka Mizusawa; Carol Ann Remme; Jean-Baptiste Gourraud; Floriane Simonet; Arie O Verkerk; Peter J Schwartz; Lia Crotti; Federica Dagradi; Pascale Guicheney; Véronique Fressart; Antoine Leenhardt; Charles Antzelevitch; Susan Bartkowiak; Martin Borggrefe; Rainer Schimpf; Eric Schulze-Bahr; Sven Zumhagen; Elijah R Behr; Rachel Bastiaenen; Jacob Tfelt-Hansen; Morten Salling Olesen; Stefan Kääb; Britt M Beckmann; Peter Weeke; Hiroshi Watanabe; Naoto Endo; Tohru Minamino; Minoru Horie; Seiko Ohno; Kanae Hasegawa; Naomasa Makita; Akihiko Nogami; Wataru Shimizu; Takeshi Aiba; Philippe Froguel; Beverley Balkau; Olivier Lantieri; Margherita Torchio; Cornelia Wiese; David Weber; Rianne Wolswinkel; Ruben Coronel; Bas J Boukens; Stéphane Bézieau; Eric Charpentier; Stéphanie Chatel; Aurore Despres; Françoise Gros; Florence Kyndt; Simon Lecointe; Pierre Lindenbaum; Vincent Portero; Jade Violleau; Manfred Gessler; Hanno L Tan; Dan M Roden; Vincent M Christoffels; Hervé Le Marec; Arthur A Wilde; Vincent Probst; Jean-Jacques Schott; Christian Dina; Richard Redon
Journal:  Nat Genet       Date:  2013-07-21       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.